But wouldn't the Chiyoda study results warrant a separate price sensitive announcement?
I doubt you would include big information like that hidden on a couple of lines within a 56-page annual report.
Ann: Appendix 4E & Annual Report 30 June 2021, page-15
Add HZR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.015(3.90%) |
Mkt cap ! $92.04M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 41.5¢ | 37.0¢ | $121.9K | 307.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 9208 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 47433 | 2 |
View Market Depth
| Last trade - 15.53pm 14/10/2024 (20 minute delay) ? |
| HZR (ASX) Chart |